A phase II trial of gemcitabine (G), cisplatin (C), and nab-paclitaxel (N) in advanced biliary tract cancers (aBTCs).

被引：7
|
作者：
Shroff, Rachna T.
Borad, Mitesh J.
Xiao, Lianchun
Kaseb, Ahmed Omar
Varadhachary, Gauri R.
Wolff, Robert A.
Raghav, Kanwal Pratap Singh
Iwasaki, Michiko
Masci, Peter
Ramanathan, Ramesh K.
Ahn, Daniel H.
Bekaii-Saab, Tanios S.
Javle, Milind M.
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Mayo Clin, Scottsdale, AZ USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA
[4] Univ Texas MD Anderson Canc Ctr, GI Med Oncol Dept, Houston, TX 77030 USA
[5] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA
[6] Mayo Clin Arizona, Scottsdale, AZ USA
[7] Mayo Clin, Canc Ctr, Phoenix, AZ USA
[8] Univ Texas MD Anderson Canc Ctr, Gastrointestinal Med Oncol, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.4018
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4018
引用
收藏
页数：5
相关论文
共 50 条
  • [41] Nab-paclitaxel (Nab) plus gemcitabine (G) is more effective than G alone in locally advanced, unresectable pancreatic cancer (LAUPC): The GAP trial, a GISCAD phase II comparative randomized trial
    Cascinu, S.
    Berardi, R.
    Bianco, R.
    Bilancia, D.
    Zaniboni, A.
    Ferrari, D.
    Mosconi, S.
    Spallanzani, A.
    Cavanna, L.
    Leo, S.
    Negri, F.
    Beretta, G. D.
    Sobrero, A.
    Banzi, M.
    Morabito, A.
    Bittoni, A.
    Marciano, R.
    Ferrara, D.
    Noventa, S.
    Piccirillo, M. C.
    ANNALS OF ONCOLOGY, 2019, 30
  • [42] A Real-World Comparison of FOLFIRINOX, Gemcitabine Plus nab-Paclitaxel, and Gemcitabine in Advanced Pancreatic Cancers
    Wang, Ying
    Camateros, Pierre
    Cheung, Winson Y.
    JOURNAL OF GASTROINTESTINAL CANCER, 2019, 50 (01) : 62 - 68
  • [43] A randomised phase 2 trial of nab-paclitaxel plus gemcitabine with or without capecitabine and cisplatin in locally advanced or borderline resectable pancreatic adenocarcinoma
    Reni, Michele
    Zanon, Silvia
    Balzano, Gianpaolo
    Passoni, Paolo
    Pircher, Chiara
    Chiaravalli, Marta
    Fugazza, Clara
    Ceraulo, Domenica
    Nicoletti, Roberto
    Arcidiacono, Paolo Giorgio
    Macchini, Marina
    Peretti, Umberto
    Castoldi, Renato
    Doglioni, Claudio
    Falconi, Massimo
    Partelli, Stefano
    Gianni, Luca
    EUROPEAN JOURNAL OF CANCER, 2018, 102 : 95 - 102
  • [44] A Real-World Comparison of FOLFIRINOX, Gemcitabine Plus nab-Paclitaxel, and Gemcitabine in Advanced Pancreatic Cancers
    Ying Wang
    Pierre Camateros
    Winson Y. Cheung
    Journal of Gastrointestinal Cancer, 2019, 50 : 62 - 68
  • [45] A phase I/II trial of combination nab-paclitaxel and nintedanib or nab-paclitaxel and placebo in relapsed NSCLC adenocarcinoma (N3)
    Tokaca, N.
    Espinasse, A.
    Petruckevitch, A.
    Ellis, S.
    Yousaf, N.
    Bhosle, J.
    O'Brien, M.
    Popat, S.
    LUNG CANCER, 2017, 103 : S77 - S78
  • [46] Nab-paclitaxel plus S-1 versus nab-paclitaxel plus gemcitabine in patients with advanced pancreatic cancer: a multicenter, randomized, phase II study
    Jin, Min
    Liu, Hong-Li
    Xue, Jun
    Ma, Hong
    Liu, Jun-Li
    Lin, Zhen-Yu
    Wang, Jing
    Bao, Le-Qun
    Luo, Zhi-Guo
    Yu, Xiong-Jie
    Li, Shuang
    Hu, Jian-Li
    Zhang, Tao
    ONCOLOGIST, 2024, 29 (10): : e1406 - e1418
  • [47] NAB-PACLITAXEL IN THE TREATMENT OF ADVANCED PANCREATIC CANCER REFRACTORY TO GEMCITABINE - FINAL RESULTS OF A PHASE 2 TRIAL
    Lopes, G. de Lima
    Hosein, P.
    Gomez, C.
    Pastorini, V.
    Macintyre, J.
    Easey, M.
    Reis, I.
    Merchan, J.
    Bejarano, P.
    Rocha-Lima, C.
    EJC SUPPLEMENTS, 2011, 9 (01): : 1 - 1
  • [48] Phase I trial of enzalutamide in combination with gemcitabine and nab-paclitaxel for the treatment of advanced pancreatic cancer.
    Mahipal, Amit
    Springett, Gregory M.
    Burke, Nancy
    Bertels, Barbara
    Wapinsky, Georgine
    Almhanna, Khaldoun
    Kim, Richard D.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [49] A phase I trial of nab-paclitaxel, gemcitabine, and capecitabine for metastatic pancreatic cancer
    Andrew H. Ko
    Thach-Giao Truong
    Emily Kantoff
    Kimberly A. Jones
    Elizabeth Dito
    Anna Ong
    Margaret A. Tempero
    Cancer Chemotherapy and Pharmacology, 2012, 70 : 875 - 881
  • [50] Gemcitabine (G) and nab-paclitaxel (nab-P) in patients with refractory advanced pancreatic cancer (PC).
    Ernani, Vinicius
    Akunyili, Ikechukwu Immanuel
    Hosein, Peter Joel
    Macintyre, Jessica
    Lima, Caio Max S. Rocha
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
12345